Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2924

TDMS Study 05133-03 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                            ACETONITRILE


NTP Experiment-Test: 05133-03                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 05/20/95
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11




       Facility:  Battelle Northwest

       Chemical CAS #:  75-05-8

       Lock Date:  05/15/92

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          56           56           56           56                                     
  Scheduled Sacrifice                                  8            8            8            8                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                24           25           21           14                                     
    Accidently Killed                                  1                                                                            
    Natural Death                                                   2            1            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                23           21           26           29                                     
  Animals Examined Microscopically                    56           56           56           56                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (56)         (56)         (56)         (55)                                   
      Mediastinum, Cyst                                                          1 (2%)                                             
   Intestine Large, Colon                             (55)         (55)         (56)         (53)                                   
      Inflammation, Suppurative                                     1 (2%)                                                          
      Lumen, Parasite Metazoan                         2 (4%)                                 1 (2%)                                
   Intestine Large, Rectum                            (55)         (56)         (56)         (53)                                   
      Ulcer                                                         1 (2%)                                                          
      Lumen, Parasite Metazoan                         2 (4%)                    6 (11%)      3 (6%)                                
   Intestine Large, Cecum                             (55)         (54)         (55)         (53)                                   
      Lumen, Parasite Metazoan                                      1 (2%)       2 (4%)                                             
   Intestine Small, Jejunum                           (55)         (55)         (56)         (53)                                   
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Intestine Small, Ileum                             (55)         (55)         (54)         (53)                                   
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Liver                                              (56)         (56)         (56)         (54)                                   
      Angiectasis                                                                             1 (2%)                                
      Atrophy                                                       1 (2%)                                                          
      Basophilic Focus                                40 (71%)     41 (73%)     38 (68%)     42 (78%)                               
      Clear Cell Focus                                 2 (4%)       2 (4%)       1 (2%)                                             
      Degeneration, Cystic                             1 (2%)                                 1 (2%)                                
      Eosinophilic Focus                                                         1 (2%)                                             
      Granuloma, Multifocal                                         4 (7%)       2 (4%)       3 (6%)                                
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)                                                          
      Hepatodiaphragmatic Nodule                       7 (13%)      3 (5%)       8 (14%)      8 (15%)                               
      Infarct                                          1 (2%)                                                                       
      Mixed Cell Focus                                                                        2 (4%)                                
      Vacuolization Cytoplasmic                       11 (20%)     14 (25%)     12 (21%)     20 (37%)                               
      Bile Duct, Hyperplasia                           2 (4%)                                                                       
      Hepatocyte, Degeneration, Cystic                              1 (2%)       1 (2%)       3 (6%)                                
      Hepatocyte, Hyperplasia                          7 (13%)      9 (16%)      4 (7%)      10 (19%)                               
      Hepatocyte, Necrosis                             1 (2%)                    3 (5%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Portal, Fibrosis                                 1 (2%)                                                                       
      Serosa, Cyst                                                  1 (2%)                                                          
      Serosa, Hemorrhage                                            1 (2%)       1 (2%)                                             
   Mesentery                                          (10)         (9)          (8)          (11)                                   
      Hemorrhage                                       1 (10%)      1 (11%)      2 (25%)      1 (9%)                                
      Artery, Inflammation                                          1 (11%)      1 (13%)                                            
      Fat, Inflammation, Granulomatous                 1 (10%)      6 (67%)      4 (50%)      7 (64%)                               
      Fat, Necrosis                                    7 (70%)      2 (22%)      4 (50%)      9 (82%)                               
   Pancreas                                           (56)         (56)         (56)         (54)                                   
      Acinus, Atrophy                                 15 (27%)     22 (39%)     29 (52%)     27 (50%)                               
      Artery, Inflammation                                                       1 (2%)       1 (2%)                                
   Salivary Glands                                    (56)         (54)         (56)         (55)                                   
      Duct, Mineralization                             1 (2%)                                                                       
   Stomach, Forestomach                               (56)         (56)         (55)         (54)                                   
      Diverticulum                                                               2 (4%)                                             
      Edema                                            2 (4%)       3 (5%)       5 (9%)                                             
      Hyperplasia, Basal Cell                                                    1 (2%)       2 (4%)                                
      Hyperplasia, Squamous                            3 (5%)       6 (11%)      8 (15%)      7 (13%)                               
      Inflammation, Suppurative                        2 (4%)       5 (9%)       4 (7%)       3 (6%)                                
      Necrosis                                                                   1 (2%)                                             
      Ulcer                                            2 (4%)       3 (5%)       5 (9%)       5 (9%)                                
   Stomach, Glandular                                 (55)         (56)         (56)         (54)                                   
      Mineralization                                                                          1 (2%)                                
      Necrosis                                         1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (56)         (56)         (56)         (55)                                   
      Aorta, Inflammation                                                        1 (2%)                                             
      Aorta, Mineralization                                                                   1 (2%)                                
   Heart                                              (56)         (56)         (56)         (55)                                   
      Cardiomyopathy                                   2 (4%)       2 (4%)       2 (4%)       2 (4%)                                
      Thrombosis                                       1 (2%)       1 (2%)                    1 (2%)                                
      Endocardium, Hyperplasia                         1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (56)         (56)         (56)         (54)                                   
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hyperplasia                                      1 (2%)       2 (4%)                                                          
      Mineralization                                                                          1 (2%)                                
      Vacuolization Cytoplasmic                        6 (11%)     11 (20%)      5 (9%)       8 (15%)                               
   Adrenal Medulla                                    (56)         (55)         (55)         (55)                                   
      Angiectasis                                                                1 (2%)                                             
      Hyperplasia                                      5 (9%)       6 (11%)      3 (5%)       1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Parathyroid Gland                                  (52)         (52)         (51)         (52)                                   
      Hyperplasia                                                                3 (6%)       1 (2%)                                
   Pituitary Gland                                    (56)         (56)         (55)         (53)                                   
      Cyst                                            13 (23%)     17 (30%)     14 (25%)     15 (28%)                               
      Pars Distalis, Cyst                              1 (2%)       1 (2%)                    1 (2%)                                
      Pars Distalis, Hemorrhage                                     1 (2%)                                                          
      Pars Distalis, Hyperplasia                       9 (16%)      5 (9%)       3 (5%)       3 (6%)                                
   Thyroid Gland                                      (56)         (56)         (56)         (54)                                   
      Dilatation                                       1 (2%)                                                                       
      Ultimobranchial Cyst                                                       1 (2%)                                             
      C-Cell, Hyperplasia                             26 (46%)     39 (70%)     36 (64%)     39 (72%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (54)         (50)         (55)         (53)                                   
      Ectasia                                         11 (20%)      4 (8%)      10 (18%)     14 (26%)                               
      Hyperplasia                                      2 (4%)       4 (8%)       4 (7%)       3 (6%)                                
      Inflammation, Suppurative                        4 (7%)       3 (6%)       2 (4%)       6 (11%)                               
   Ovary                                              (56)         (56)         (56)         (55)                                   
      Cyst                                             4 (7%)       3 (5%)       2 (4%)       5 (9%)                                
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Uterus                                             (56)         (56)         (56)         (55)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Thrombosis                                       1 (2%)                                                                       
      Cervix, Endometrium, Hyperplasia                              1 (2%)       1 (2%)                                             
      Endometrium, Hyperplasia                         1 (2%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (56)         (56)         (56)         (54)                                   
      Hyperplasia, Re Cell                             1 (2%)       3 (5%)       2 (4%)       1 (2%)                                
      Myelofibrosis                                                 2 (4%)                                                          
   Lymph Node                                         (7)          (6)          (9)          (8)                                    
      Axillary, Hyperplasia, Lymphoid                                            1 (11%)                                            
      Iliac, Pigmentation                                                        1 (11%)                                            
      Lumbar, Pigmentation                             1 (14%)                                                                      
      Pancreatic, Hemorrhage                                        1 (17%)                                                         
      Pancreatic, Pigmentation                                                   1 (11%)                                            
      Renal, Hemorrhage                                             1 (17%)      1 (11%)                                            
   Lymph Node, Bronchial                              (49)         (44)         (45)         (48)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hemorrhage                                       4 (8%)       1 (2%)                    2 (4%)                                
      Inflammation, Suppurative                        1 (2%)                                                                       
   Lymph Node, Mandibular                             (54)         (54)         (52)         (49)                                   
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)       4 (8%)                                             
   Lymph Node, Mesenteric                             (54)         (55)         (55)         (55)                                   
      Hemorrhage                                                    3 (5%)                    2 (4%)                                
      Hyperplasia, Lymphoid                            2 (4%)       1 (2%)                                                          
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Lymph Node, Mediastinal                            (56)         (53)         (53)         (54)                                   
      Hemorrhage                                      11 (20%)      7 (13%)      3 (6%)      11 (20%)                               
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Pigmentation                                                                            1 (2%)                                
   Spleen                                             (56)         (56)         (56)         (53)                                   
      Developmental Malformation                                                              1 (2%)                                
      Fibrosis                                         1 (2%)       2 (4%)       1 (2%)       3 (6%)                                
      Hematopoietic Cell Proliferation                                                        1 (2%)                                
      Hemorrhage                                       1 (2%)                    2 (4%)                                             
      Hyperplasia, Re Cell                             2 (4%)       3 (5%)       1 (2%)                                             
      Necrosis                                         1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
   Thymus                                             (56)         (56)         (55)         (55)                                   
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (56)         (56)         (56)         (55)                                   
      Galactocele                                                   2 (4%)       2 (4%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Skin                                               (56)         (56)         (56)         (56)                                   
      Acanthosis                                                    1 (2%)       1 (2%)                                             
      Inflammation, Granulomatous                                                2 (4%)       1 (2%)                                
      Inflammation, Suppurative                        1 (2%)       2 (4%)                                                          
      Ulcer                                                         2 (4%)       1 (2%)       2 (4%)                                
      Subcutaneous Tissue, Hemorrhage                                            1 (2%)                                             
      Subcutaneous Tissue, Necrosis                                                           1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (55)         (56)         (56)         (55)                                   
      Fibrosis                                                                                1 (2%)                                
      Periosteum, Cranium, Hemorrhage                                                         1 (2%)                                
      Vertebra, Fracture                               1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (56)         (56)         (56)         (55)                                   
      Hemorrhage                                       4 (7%)       5 (9%)       8 (14%)      2 (4%)                                
      Hydrocephalus                                    4 (7%)       6 (11%)      3 (5%)       5 (9%)                                
      Necrosis                                         1 (2%)                                                                       
   Spinal Cord                                        (1)                                                                           
      Hemorrhage                                       1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (55)         (56)         (56)         (54)                                   
      Foreign Body                                     8 (15%)      2 (4%)       4 (7%)       4 (7%)                                
      Hyperplasia                                      5 (9%)       1 (2%)       3 (5%)       4 (7%)                                
      Inflammation, Suppurative                        5 (9%)                    6 (11%)      3 (6%)                                
      Metaplasia, Squamous                             7 (13%)      5 (9%)       7 (13%)      3 (6%)                                
      Mineralization                                                             1 (2%)                                             
   Lung                                               (56)         (56)         (56)         (54)                                   
      Hemorrhage                                      43 (77%)     37 (66%)     40 (71%)     38 (70%)                               
      Infiltration Cellular, Histiocyte               11 (20%)     17 (30%)     17 (30%)     13 (24%)                               
      Metaplasia, Osseous                                                        1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 6 (11%)      5 (9%)       2 (4%)       1 (2%)                                
      Alveolus, Fibrosis                               2 (4%)       1 (2%)       1 (2%)                                             
      Alveolus, Inflammation, Chronic                  3 (5%)       1 (2%)                    1 (2%)                                
      Alveolus, Inflammation, Suppurative              2 (4%)                                                                       
      Pleura, Fibrosis                                 3 (5%)       2 (4%)       2 (4%)       1 (2%)                                
   Nose                                               (55)         (55)         (56)         (54)                                   
      Foreign Body                                     2 (4%)       5 (9%)       1 (2%)       3 (6%)                                
      Hemorrhage                                                    1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic                            1 (2%)                    1 (2%)       2 (4%)                                
      Inflammation, Suppurative                        1 (2%)       2 (4%)       3 (5%)       2 (4%)                                
      Goblet Cell, Respiratory Epithelium,                                                                                          
          Hypertrophy                                  3 (5%)       2 (4%)       2 (4%)       4 (7%)                                
      Nasolacrimal Duct, Inflammation, Suppurative                  3 (5%)                    2 (4%)                                
      Olfactory Epithelium, Metaplasia                                                        1 (2%)                                
      Respiratory Epithelium, Hyperplasia              2 (4%)       2 (4%)       2 (4%)       1 (2%)                                
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)       1 (2%)                                
   Trachea                                            (56)         (56)         (56)         (53)                                   
      Epithelium, Hyperplasia                                                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (4)          (2)          (4)          (4)                                    
      Cataract                                         1 (25%)                   2 (50%)      1 (25%)                               
      Hemorrhage                                       2 (50%)      1 (50%)      2 (50%)      1 (25%)                               
      Retina, Atrophy                                                            1 (25%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (56)         (56)         (56)         (54)                                   
      Infarct                                                       1 (2%)                                                          
      Nephropathy, Chronic                            40 (71%)     38 (68%)     38 (68%)     40 (74%)                               
      Cortex, Necrosis                                 5 (9%)       2 (4%)       5 (9%)       5 (9%)                                
      Pelvis, Transitional Epithelium, Hyperplasia                  1 (2%)                                                          
      Renal Tubule, Inflammation, Suppurative                       1 (2%)                                                          
      Renal Tubule, Mineralization                    44 (79%)     42 (75%)     48 (86%)     41 (76%)                               
      Renal Tubule, Pigmentation, Hemosiderin                       1 (2%)                                                          
   Urinary Bladder                                    (56)         (56)         (55)         (53)                                   
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          56           56           56           56                                     
  Scheduled Sacrifice                                  8            8            8            8                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                36           26           35           26                                     
    Natural Death                                      1            8            4            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                11           13            9           17                                     
  Other                                                             1                                                               
  Animals Examined Microscopically                    56           56           56           56                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (56)         (50)         (54)         (53)                                   
      Lumen, Parasite Metazoan                         4 (7%)       2 (4%)       4 (7%)       1 (2%)                                
   Intestine Large, Rectum                            (55)         (52)         (55)         (54)                                   
      Lumen, Parasite Metazoan                         4 (7%)       4 (8%)       6 (11%)      5 (9%)                                
   Intestine Large, Cecum                             (55)         (51)         (54)         (52)                                   
      Lumen, Parasite Metazoan                         4 (7%)       3 (6%)       1 (2%)                                             
   Intestine Small, Duodenum                          (55)         (53)         (56)         (55)                                   
      Diverticulum                                                  1 (2%)                                                          
   Intestine Small, Jejunum                           (55)         (50)         (54)         (52)                                   
      Parasite Metazoan                                1 (2%)                                 1 (2%)                                
   Liver                                              (56)         (55)         (56)         (56)                                   
      Angiectasis                                                   1 (2%)       1 (2%)                                             
      Basophilic Focus                                21 (38%)     28 (51%)     32 (57%)     38 (68%)                               
      Clear Cell Focus                                 6 (11%)      1 (2%)       2 (4%)       7 (13%)                               
      Degeneration, Cystic                            16 (29%)     17 (31%)      8 (14%)      4 (7%)                                
      Eosinophilic Focus                               3 (5%)       7 (13%)      5 (9%)      10 (18%)                               
      Granuloma, Multifocal                                         1 (2%)                                                          
      Hematopoietic Cell Proliferation                 2 (4%)                                                                       
      Hepatodiaphragmatic Nodule                       2 (4%)       4 (7%)       5 (9%)       3 (5%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
      Mixed Cell Focus                                 1 (2%)       1 (2%)       1 (2%)       5 (9%)                                
      Pigmentation, Hemosiderin                                     1 (2%)                                                          
      Thrombosis                                                                              2 (4%)                                
      Vacuolization Cytoplasmic                       11 (20%)     10 (18%)     12 (21%)      5 (9%)                                
      Bile Duct, Hyperplasia                           2 (4%)       2 (4%)       3 (5%)                                             
      Hepatocyte, Necrosis                             7 (13%)      8 (15%)      1 (2%)       3 (5%)                                
      Portal, Fibrosis                                 1 (2%)                                                                       
   Mesentery                                          (10)         (9)          (9)          (12)                                   
      Hemorrhage                                       3 (30%)                   1 (11%)      4 (33%)                               
      Fat, Inflammation, Granulomatous                 1 (10%)      1 (11%)      3 (33%)      2 (17%)                               
      Fat, Necrosis                                    7 (70%)      7 (78%)      1 (11%)      8 (67%)                               
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Pancreas                                           (56)         (55)         (56)         (56)                                   
      Hemorrhage                                                                              2 (4%)                                
      Acinus, Atrophy                                 24 (43%)     35 (64%)     29 (52%)     31 (55%)                               
      Artery, Inflammation                                          1 (2%)                    2 (4%)                                
      Duct, Cyst                                       1 (2%)       1 (2%)                                                          
      Duct, Hyperplasia                                             1 (2%)                                                          
   Stomach, Forestomach                               (56)         (55)         (56)         (55)                                   
      Acanthosis                                       4 (7%)       4 (7%)      10 (18%)      4 (7%)                                
      Diverticulum                                                               2 (4%)       2 (4%)                                
      Edema                                            1 (2%)       3 (5%)       1 (2%)                                             
      Hyperkeratosis                                                2 (4%)                                                          
      Inflammation, Suppurative                        5 (9%)       4 (7%)       7 (13%)      1 (2%)                                
      Mineralization                                                1 (2%)       1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Ulcer                                            4 (7%)       3 (5%)       7 (13%)      3 (5%)                                
   Stomach, Glandular                                 (56)         (54)         (56)         (55)                                   
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Mineralization                                                1 (2%)       1 (2%)       1 (2%)                                
      Necrosis                                                      1 (2%)       1 (2%)                                             
      Ulcer                                            1 (2%)                    1 (2%)                                             
   Tongue                                                          (2)                       (1)                                    
      Epithelium, Hyperplasia                                       1 (50%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (56)         (54)         (56)         (56)                                   
      Mineralization                                   1 (2%)                                                                       
      Aorta, Inflammation                              1 (2%)       1 (2%)                                                          
      Aorta, Mineralization                                         2 (4%)       1 (2%)                                             
   Heart                                              (56)         (55)         (56)         (56)                                   
      Cardiomyopathy                                  14 (25%)     11 (20%)     12 (21%)     11 (20%)                               
      Atrium, Thrombosis                               8 (14%)      3 (5%)       3 (5%)       1 (2%)                                
      Myocardium, Mineralization                                    1 (2%)       1 (2%)                                             
      Myocardium, Necrosis                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (56)         (55)         (56)         (56)                                   
      Hemorrhage                                                    1 (2%)       2 (4%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Vacuolization Cytoplasmic                        7 (13%)      8 (15%)     10 (18%)      7 (13%)                               
   Adrenal Medulla                                    (56)         (53)         (53)         (56)                                   
      Hyperplasia                                     20 (36%)     16 (30%)     21 (40%)     16 (29%)                               
   Islets, Pancreatic                                 (56)         (55)         (56)         (56)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                      1 (2%)                    2 (4%)                                             
   Parathyroid Gland                                  (54)         (49)         (54)         (49)                                   
      Hyperplasia                                      2 (4%)       5 (10%)      4 (7%)       2 (4%)                                
   Pituitary Gland                                    (56)         (53)         (56)         (54)                                   
      Cyst                                             3 (5%)       7 (13%)      8 (14%)      4 (7%)                                
      Hemorrhage                                       1 (2%)       2 (4%)       1 (2%)                                             
      Pars Distalis, Hemorrhage                        1 (2%)                                                                       
      Pars Distalis, Hyperplasia                       8 (14%)      9 (17%)      9 (16%)     10 (19%)                               
      Pars Intermedia, Hyperplasia                                  1 (2%)                                                          
   Thyroid Gland                                      (56)         (55)         (56)         (56)                                   
      Ultimobranchial Cyst                                                       2 (4%)                                             
      C-Cell, Hyperplasia                             10 (18%)     10 (18%)      9 (16%)     12 (21%)                               
      Follicle, Dilatation                             1 (2%)                                                                       
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (56)         (55)         (56)         (56)                                   
      Inflammation, Suppurative                                                  1 (2%)                                             
   Preputial Gland                                    (55)         (55)         (55)         (56)                                   
      Ectasia                                         22 (40%)     16 (29%)     25 (45%)     16 (29%)                               
      Granuloma                                                     1 (2%)                                                          
      Hyperplasia                                      1 (2%)       2 (4%)       2 (4%)       3 (5%)                                
      Inflammation, Chronic                            1 (2%)                    4 (7%)                                             
      Inflammation, Suppurative                        7 (13%)      7 (13%)      6 (11%)      8 (14%)                               
   Prostate                                           (56)         (55)         (56)         (56)                                   
      Cyst                                                          1 (2%)                                                          
      Inflammation, Suppurative                        9 (16%)     10 (18%)      9 (16%)     12 (21%)                               
      Epithelium, Hyperplasia                          1 (2%)       1 (2%)       1 (2%)       2 (4%)                                
   Seminal Vesicle                                    (56)         (54)         (56)         (56)                                   
      Hyperplasia                                                   1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Suppurative                        1 (2%)       2 (4%)       2 (4%)                                             
   Testes                                             (56)         (55)         (56)         (56)                                   
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Germinal Epithelium, Atrophy                    10 (18%)     13 (24%)      9 (16%)      9 (16%)                               
      Interstitial Cell, Hyperplasia                  21 (38%)     19 (35%)     21 (38%)      9 (16%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (56)         (55)         (56)         (56)                                   
      Hyperplasia, Re Cell                             7 (13%)                   1 (2%)                                             
      Myelofibrosis                                    2 (4%)                                                                       
   Lymph Node                                         (12)         (8)          (15)         (13)                                   
      Inflammation, Granulomatous                      1 (8%)                                                                       
      Iliac, Pigmentation                                                                     1 (8%)                                
      Lumbar, Pigmentation                             1 (8%)       1 (13%)      2 (13%)      1 (8%)                                
      Pancreatic, Hyperplasia, Lymphoid                                                       1 (8%)                                
      Renal, Ectasia                                                1 (13%)                                                         
      Renal, Hemorrhage                                                                       1 (8%)                                
      Renal, Pigmentation                                                        1 (7%)       1 (8%)                                
   Lymph Node, Mandibular                             (49)         (51)         (52)         (54)                                   
      Hemorrhage                                                    1 (2%)                    1 (2%)                                
      Hyperplasia, Lymphoid                                         2 (4%)       1 (2%)                                             
   Lymph Node, Mesenteric                             (55)         (55)         (55)         (56)                                   
      Hemorrhage                                       1 (2%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Inflammation, Granulomatous                                   1 (2%)                                                          
   Lymph Node, Mediastinal                            (56)         (53)         (56)         (56)                                   
      Fibrosis                                                                   3 (5%)                                             
      Hemorrhage                                       1 (2%)       5 (9%)       1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Pigmentation                                     1 (2%)       1 (2%)                                                          
   Spleen                                             (56)         (55)         (56)         (56)                                   
      Congestion                                                                              1 (2%)                                
      Developmental Malformation                                    2 (4%)       2 (4%)       2 (4%)                                
      Fibrosis                                         7 (13%)     13 (24%)     18 (32%)     15 (27%)                               
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Re Cell                             4 (7%)       1 (2%)                                                          
      Necrosis                                                      1 (2%)       2 (4%)                                             
   Thymus                                             (55)         (52)         (54)         (56)                                   
      Hemorrhage                                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (55)         (55)         (56)         (56)                                   
      Galactocele                                      1 (2%)       2 (4%)       3 (5%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Epithelium, Hyperplasia                                       1 (2%)       3 (5%)       1 (2%)                                
   Skin                                               (56)         (55)         (56)         (56)                                   
      Acanthosis                                       2 (4%)       2 (4%)       3 (5%)                                             
      Cyst                                                          1 (2%)                                                          
      Cyst Epithelial Inclusion                                     2 (4%)       1 (2%)       1 (2%)                                
      Hyperkeratosis                                   1 (2%)       2 (4%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Granulomatous                      2 (4%)       1 (2%)       3 (5%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Ulcer                                            4 (7%)       1 (2%)       1 (2%)       1 (2%)                                
      Subcutaneous Tissue, Hemorrhage                               1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (56)         (55)         (56)         (56)                                   
      Developmental Malformation                                    1 (2%)                                                          
      Fibrosis                                                      1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (56)         (55)         (56)         (56)                                   
      Demyelination                                                 1 (2%)                                                          
      Gliosis                                          1 (2%)                                                                       
      Hemorrhage                                       3 (5%)       5 (9%)       6 (11%)      4 (7%)                                
      Hydrocephalus                                    7 (13%)      7 (13%)      7 (13%)      2 (4%)                                
      Necrosis                                                      1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (56)         (54)         (56)         (56)                                   
      Foreign Body                                     4 (7%)       4 (7%)       5 (9%)       9 (16%)                               
      Hyperplasia                                      1 (2%)       4 (7%)       1 (2%)       4 (7%)                                
      Inflammation, Suppurative                        5 (9%)       3 (6%)       4 (7%)       8 (14%)                               
      Metaplasia, Squamous                             1 (2%)       2 (4%)       1 (2%)                                             
      Mineralization                                                1 (2%)                    1 (2%)                                
   Lung                                               (56)         (55)         (56)         (56)                                   
      Embolus                                          1 (2%)                                                                       
      Hemorrhage                                      24 (43%)     37 (67%)     34 (61%)     35 (63%)                               
      Infarct                                                                    1 (2%)                                             
      Infiltration Cellular, Histiocyte               10 (18%)     16 (29%)     14 (25%)     11 (20%)                               
      Metaplasia, Osseous                                           1 (2%)                                                          
      Thrombosis                                                                 1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 3 (5%)       7 (13%)      4 (7%)      10 (18%)                               
      Alveolus, Fibrosis                               2 (4%)       1 (2%)       7 (13%)                                            
      Alveolus, Inflammation, Chronic                  4 (7%)                                 2 (4%)                                
      Alveolus, Mineralization                                      1 (2%)       1 (2%)                                             
      Alveolus, Pigmentation                                        1 (2%)       1 (2%)                                             
      Artery, Inflammation, Chronic Active                                       1 (2%)                                             
      Pleura, Fibrosis                                 1 (2%)                                 1 (2%)                                
   Nose                                               (56)         (55)         (56)         (56)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05133-03         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                            ACETONITRILE                                       Date: 05/20/95  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 06:11:11  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      100 PPM      200 PPM      400 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Foreign Body                                    10 (18%)      9 (16%)      7 (13%)      7 (13%)                               
      Hemorrhage                                       6 (11%)      3 (5%)       2 (4%)       5 (9%)                                
      Inflammation, Chronic                            2 (4%)       2 (4%)       3 (5%)       2 (4%)                                
      Inflammation, Suppurative                        4 (7%)       4 (7%)       6 (11%)     10 (18%)                               
      Goblet Cell, Respiratory Epithelium,                                                                                          
          Hypertrophy                                  9 (16%)      4 (7%)       8 (14%)      3 (5%)                                
      Nasolacrimal Duct, Inflammation                                                         1 (2%)                                
      Nasopharyngeal Duct, Hyperplasia                                                        1 (2%)                                
      Olfactory Epithelium, Metaplasia                              1 (2%)                                                          
      Respiratory Epithelium, Hyperplasia              5 (9%)       5 (9%)       6 (11%)      8 (14%)                               
   Trachea                                            (56)         (55)         (56)         (56)                                   
      Peritracheal Tissue, Fibrosis                                                           1 (2%)                                
      Peritracheal Tissue, Inflammation, Chronic                                                                                    
          Active                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (1)          (2)          (2)                                    
      Cataract                                                      1 (100%)                  2 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (56)         (55)         (56)         (56)                                   
      Nephropathy, Chronic                            52 (93%)     55 (100%)    55 (98%)     56 (100%)                              
      Thrombosis                                       1 (2%)                                                                       
      Cortex, Necrosis                                 1 (2%)       1 (2%)       3 (5%)                                             
      Pelvis, Dilatation                                            1 (2%)                    1 (2%)                                
      Pelvis, Transitional Epithelium, Hyperplasia     3 (5%)       3 (5%)       1 (2%)       1 (2%)                                
      Renal Tubule, Hyperplasia                        1 (2%)                    1 (2%)                                             
      Renal Tubule, Mineralization                                  1 (2%)       1 (2%)                                             
   Urinary Bladder                                    (56)         (55)         (56)         (56)                                   
      Hemorrhage                                       2 (4%)       1 (2%)                                                          
      Inflammation, Suppurative                                     1 (2%)                                                          
      Metaplasia, Squamous                             1 (2%)                                                                       
      Mineralization                                                1 (2%)                                                          
      Ulcer                                            1 (2%)                                                                       
      Transitional Epithelium, Hyperplasia                          2 (4%)                    2 (4%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------